Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202669 · ClinicalTrials.gov registry record
Heart Rate Changes in Subjects With Epilepsy
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 98
- Enrollment target
NCT01202669: Completed study, sponsored by Cyberonics.
NCT01202669 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01202669 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to collect continuous observational data during a clinical Epilepsy Monitoring Unit evaluation.
Primary Outcome
To collect continuous observational video, electroencephalogram (EEG), electrooculogram (EOG), and electrocardiogram (ECG) data during ictal and non-ictal events occurring over a clinical EMU evaluation.
Interventions
- OTHER No intervention planned, observational study only.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-07 |
What the finished NCT01202669 record still lists
NCT01202669 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention planned, observational study only. is the first listed.
NCT01202669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01202669 about?
NCT01202669 is a clinical study titled "Heart Rate Changes in Subjects With Epilepsy". The purpose of this study is to collect continuous observational data during a clinical Epilepsy Monitoring Unit evaluation.
What is the current status of trial NCT01202669?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2010-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01202669?
The interventions under investigation include: No intervention planned, observational study only. (OTHER).
Who is sponsoring clinical trial NCT01202669?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia